To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 1, 2006
Referred to the Subcommittee on Health.
Jul 28, 2006
Referred to the House Committee on Energy and Commerce.
Jul 28, 2006
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
4
Cite this page
U.S. Congress. (2026). H.R. 5993: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.. 109th Congress. Open America. https://openamerica.io/bill/109-HR-5993/
"H.R. 5993: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-5993/.
H.R. 5993, 109th Cong. (2026), https://openamerica.io/bill/109-HR-5993/.
[H.R. 5993: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.](https://openamerica.io/bill/109-HR-5993/)